According to a recently published studies, GLP-1RAs reduce glycated hemoglobin (HbA1c) levels and body mass index in patients with T2DM, as well as the risk of developing AD and related dementias by 26% [38, 39]
Matsuo 1992
Clinical, surgical, pharmacological, and nutritionalbehavioral domains Clinical domain A comprehensive clinical assessment of patients with obesity requires consideration of both family and personal medical history, enabling the identification of predisposing risk factors and comorbid conditions essential for personalized treatment planning
Engagement of its target receptor, the GLP-1R, is likely one factor contributing to the faster clearance rate for the GLP-1 albumin fusion
[Abstract]2026 May 22;45(6):117427
Some people started on a smaller dose and experienced less side effects